<?xml version="1.0" encoding="UTF-8"?>
<funding-group>
 <award-group id="award001">
  <funding-source>
   <institution>CIRCB</institution>
  </funding-source>
  <award-id>Annual budget 2017</award-id>
 </award-group>
 <award-group id="award002">
  <funding-source>
   <institution-wrap>
    <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100001713</institution-id>
    <institution>European and Developing Countries Clinical Trials Partnership</institution>
   </institution-wrap>
  </funding-source>
  <award-id>CDF-TMA 1027</award-id>
  <principal-award-recipient>
   <contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-1501-2763</contrib-id>
   <name>
    <surname>Fokam</surname>
    <given-names>Joseph</given-names>
   </name>
  </principal-award-recipient>
 </award-group>
 <funding-statement>This study was financially supported by the Chantal BIYA International Reference Center for research on HIV/AIDS prevention and management, in Yaounde, Cameroon. The study was partly supported by EDCTP2, the European and Developing Countries Clinical Trial Partnership, CDF-TMA 1027, which facilitated the relocation at CIRCB of the principal investigator: Dr. Joseph Fokam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
